Catching a complex for optimal signaling
- PMID: 31541026
- PMCID: PMC6755816
- DOI: 10.1074/jbc.H119.010823
Catching a complex for optimal signaling
Abstract
Agonistic antibodies are powerful tools to dimerize receptors in the absence of ligand binding, but high-fidelity receptor activation requires that these antibodies accurately recapitulate the native dimeric state. Spangler et al. employ a clever approach to select for antibodies that bind a specific IL-4Rα/γc heterodimeric complex in its native signaling conformation, leading to a monovalent "stapler," a single-chain variable fragment (scFv) that binds at the dimerization interface. This powerful approach can be further exploited for a variety of homo- or heterodimeric receptors to achieve signaling, especially in the absence of endogenous ligand.
© 2019 Zajonc.
Conflict of interest statement
The author declares that he has no conflicts of interest with the contents of this article.
Comment on
-
A strategy for the selection of monovalent antibodies that span protein dimer interfaces.J Biol Chem. 2019 Sep 20;294(38):13876-13886. doi: 10.1074/jbc.RA119.009213. Epub 2019 Aug 6. J Biol Chem. 2019. PMID: 31387945 Free PMC article.
References
-
- Zhang P., Tu G. H., Wei J., Santiago P., Larrabee L. R., Liao-Chan S., Mistry T., Chu M. L., Sai T., Lindquist K., Long H., Chaparro-Riggers J., Salek-Ardakani S., and Yeung Y. A. (2019) Ligand-blocking and membrane-proximal domain targeting anti-OX40 antibodies mediate potent T cell-stimulatory and anti-tumor activity. Cell Rep. 27, 3117–3123.e5 10.1016/j.celrep.2019.05.027 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources